Notice to stakeholders: Harmonizing fludeoxyglucose (F-18 FDG) product monographs
Health Canada recommends modified wording for the indications and clinical uses of fludeoxyglucose (F-18 FDG) products in their product monographs. The modified wording aims to bring the indications and clinical uses for F-18 FDG up-to-date and harmonize the product monographs in this regard.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2021-12-29
Data overview
- Formats
- HTML
- File languages
- English, French